Table 1 Baseline characteristics, investigations, and scores

40.48 ± 11.38

40 (17)

51.16 ± 8.55

51 (9)

0.001^#

Sex

Female

131 (28.6%)

65 (32.0%)

0.406

Male

327 (71.4%)

138 (68.0%)

IHA Sch.

Negative

320 (89.4%)

43 (78.2%)

0.025

Positive

38 (10.6%)

12 (21.8%)

1.26 ± 1.74

0.85 (0.5)

2.01 ± 2.16

1.5 (1.4)

0.001^#

3.96 ± 0.82

4.2 (0.8)

3.09 ± 0.81

3.1 (1.1)

0.001^#

55.43 ± 41.26

45 (34)

78.40 ± 115.99

59 (47)

0.001^#

55.59 ± 48.14

45 (34)

57.41 ± 75.28

46 (39)

0.912^#

64.47 87.14

32 (56.5)

63.70 ± 69.60

34 (52)

0.338^#

13.48 ± 1.51

13.5 (2.1)

12.25 ± 3.06

12 (2.8)

0.001^#

6.52 ± 7.16

5.9 (3)

4.60 ± 1.44

4.45 (2)

0.001^#

175.99 ± 66.72

175 (90)

92.42 ± 39.39

89 (54)

0.001

Platelets (/mm³)

≥ 15010⁹/L

308 (96%)

13 (4%)

0.001

< 15010⁹/L

150 (44.1%)

190 (55.9%)

1.17 ± 0.28

1.1 (0.2)

1.33 ± 0.28

1.3 (0.2)

0.001^#

11.39 ± 1.53

11 (2)

13.17 ± 2.36

13 (2)

0.001^#

9.28 ± 1.09

9 (1)

9.60 ± 1.51

9 (1)

0.052^#

17.54 ± 6.46

16.8 (7.9)

31.92 ± 13.29

29.6 (16.7)

0.001^#

− 2.58 ± 0.84

− 2.84 (0.7)

− 1.71 ± 0.81

− 1.68 (1.16)

0.001^#

ALBI grade

1

310 (67.7%)

31 (15.3%)

0.001

2

91 (19.9%)

106 (52.2%)

3

57 (12.4%)

66 (32.5%)

2.83 ± 1.04

2 (2)

3.99 ± 0.88

4 (1)

0.001^#

ALBI-PLT grade

2

249 (54.4%)

17 (8.4%)

0.001

3

85 (18.6%)

29 (14.3%)

4

78 (17%)

96 (47.3%)

5

46 (10%)

61 (30%)

− 2.46 ± 0.51

− 2.09 ± 0.55

0.001

PALBI grade

1

252 (55%)

46 (22.7%)

0.001

2

128 (27.9%)

55 (27.1%)

3

78 (17%)

102 (50.2%)

1.82 ± 5.03

0.83 (1.28)

1.57 ± 1.61

0.99 (1.2)

0.197^#